Clinical trials: mRNA Vaccination
SARS-CoV-2
Clinical Trail of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021) in Participants Aged 18 Years and Older
This is a multi-center, randomized, blinded, placebo-controlled, phase 3 clinical study to evaluate the efficacy, safety and immunogenicity of SARS-CoV-2 bivalent mRNA vaccine (LVRNA021) as booster in participants aged 18 years…
- Trial name
- NCT05812014
- Testing
- SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021), 0.9% sodium chloride solution
- Where
- Pakistan
- Volunteers
- 9,800 people, healthy volunteers welcome
- Sponsor
- AIM Vaccine Co., Ltd.